Keith Karcher, MS | Psychiatrist.com

Original Research

Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic

October 15, 2003

W. Wolfgang Fleischhacker, Mariëlle Eerdekens, Keith Karcher, et al